{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T21:03:19Z","timestamp":1789333399615,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016947","name":"Swim Across America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clml.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:30:16Z","timestamp":1787391016000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4192-8708","authenticated-orcid":false,"given":"Cristina A.","family":"Perez-Witte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-7772","authenticated-orcid":false,"given":"Natalie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip T.","family":"Pauerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilianne M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Winestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-5281","authenticated-orcid":false,"given":"Robert E.","family":"Goldsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2026.08.013_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.013_bib0002","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s12015-021-10230-x","article-title":"The fetal-to-adult hematopoietic stem cell transition and its role in childhood hematopoietic malignancies","volume":"17","author":"Mack","year":"2021","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.clml.2026.08.013_bib0003","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clml.2026.08.013_bib0004","first-page":"1","article-title":"Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia-A comprehensive review","author":"de Kluis","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clml.2026.08.013_bib0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjh.15246","article-title":"Neonatal leukaemia","volume":"182","author":"Roberts","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2026.08.013_bib0006","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3324\/haematol.2024.285642","article-title":"KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges","volume":"110","author":"Stutterheim","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2026.08.013_bib0007","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2026.08.013_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061061","article-title":"One size does not fit all: heterogeneity in developmental hematopoiesis","volume":"11","author":"Barone","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clml.2026.08.013_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2023023154","article-title":"How I treat infant acute lymphoblastic leukemia","volume":"145","author":"Bartram","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.013_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2018-04-785980","article-title":"How I treat infant leukemia","volume":"133","author":"Brown","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.013_bib0011","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood.2021011694","article-title":"How I treat pediatric acute myeloid leukemia","volume":"138","author":"Rubnitz","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.013_bib0012","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3324\/haematol.2025.288481","article-title":"Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia","volume":"111","author":"Shoji","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2026.08.013_bib0013","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41375-018-0071-7","article-title":"Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012","volume":"32","author":"Rasche","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2026.08.013_bib0014","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","article-title":"Collaborative efforts driving progress in pediatric acute myeloid leukemia","volume":"33","author":"Zwaan","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2026.08.013_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040777","article-title":"Infant acute myeloid leukemia: a unique clinical and biological entity","volume":"13","author":"Calvo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clml.2026.08.013_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28940","article-title":"Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia","volume":"68","author":"Ibrahimova","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2026.08.013_bib0017","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2411680","article-title":"Blinatumomab in standard-risk B-cell acute lymphoblastic leukemia in children","volume":"392","author":"Gupta","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2026.08.013_bib0018","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1182\/blood.2023022480","article-title":"Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias","volume":"144","author":"Kwon","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clml.2026.08.013_bib0019","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","volume":"388","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2026.08.013_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","article-title":"Menin inhibition with Revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101)","volume":"43","author":"Issa","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502603274X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226502603274X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:04:05Z","timestamp":1789329845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226502603274X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S215226502603274X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.013","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}